Skip Ribbon Commands
Skip to main content

Research Programs

:

Research Programs > CancerCenterClinicalTrials
Cancer Center Clinical Trials
Official Title:Patterns of Erectile Recovery after Radical Retropubic Prostatectomy with Sildenafil Therapy
Date Window: 1/9/2013 - 2/9/2015
Contact for Details:Judith Travis, RN 301-319-2927
Summary:Purpose is to determine if early and continuous use of Viagra after prostatectomy helps improve erectile function.  Men with normal erectile function must enroll prior to surgery, study lasts 13 months, visits coincide with standard post-op clinic visits. 

Official Title:GOG 258: A Randomized Phase III Trial of Cisplatin and Tumor Volume Directed Irradiation Followed by
Date Window: 11/9/2010 - 11/9/2015
Contact for Details:Karen Harrington; 301.400.1274
Summary:This randomized phase III trial is studying carboplatin and paclitaxel to see how well they work when given with or without cisplatin and radiation therapy in treating patients with stage I, stage II, stage III, or stage IVA endometrial cancer.

Official Title:CALGB 30607: Randomized, Phase III, Double-Blind Placebo-Controlled Trial of Sunitinib as Maintenance Therapy in Non-Progressing Patients Following an Initial Four Cycles of Platinum-Based Combination Chemotherapy in Advanced, Stage IIIB / IV Non-Small Ce
Date Window: 5/27/2009 - 5/27/2014
Contact for Details:Brenda Davis, RN 301-319-2367 or Ketly Bateau-Walker, RN 310-295-4374
Summary:To test how well sunitib works at preventing lung cancer recurrence or progression when given as maintenance therapy after standard chemotherapy treatment for advanced non small cell lung cancer. 

ClinicalTrials.gov identifier

NCT00693992

Official Title:CALGB 90203: A Randomized Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation Prior to Radical Prostatectomy Versus Immediate Radical Prostatectomy in Patients with High-Risk, Clinically Localized Prostate Cancer
Date Window: 3/8/2007 - 3/8/2014
Contact for Details:Brenda Davis, RN 301-319-2367 or Ketly Bateau-Walker, RN 310-295-4374
Summary:
To test how well chemotherapy and hormonal therapy work to prevent prostate cancer recurrence when given before standard surgery.

 
ClinicalTrials.gov identifier
NCT00430183


Official Title:CALGB 50303: Phase III Randomized Study of R-CHOP Versus Dose-Adjusted EPOCH-R with Molecular Profiling in Untreated De Novo Diffuse Large B-Cell Lymphomas
Date Window: 7/26/2005 - 7/26/2014
Contact for Details:Brenda Davis, RN 301-319-2367 or Ketly Bateau-Walker, RN 310-295-4374
Summary:To compare the effectiveness of two different chemotherapy regimens for treating diffuse large B cell lymphoma.

ClinicalTrials.gov identifier
NCT00118209

Official Title:ECOG 2905: Randomized Phase III Trial Comparing the Frequency of Major Erythroid Response (MER) to Treatment with Lenalidomide Alone and in Combination with Epoetin Alfa in Subjects with Low- or Intermediate-1 Risk myelodysplastic syndrome (MDS) and Sympt
Date Window: 10/27/2009 - 10/27/2014
Contact for Details:Brenda Davis, RN 301-319-2367 or Ketly Bateau-Walker, RN 310-295-4374
Summary:To test how well lenalidomide works with or without epoetin alfa to treat anemia in patients with myelodysplastic syndrome.

ClinicalTrials.gov identifier
NCT00843882


Official Title:CALGB 30801: A Randomized Phase III Double Blind Trial Evaluating Selective COX-2 Inhibition In COX-2 Expressing Advanced Non-Small Cell Lung Cancer
Date Window: 6/8/2010 - 6/8/2015
Contact for Details:Brenda Davis, RN 301-319-2367 or Ketly Bateau-Walker, RN 310-295-4374
Summary:
ClinicalTrials.gov identifier
NCT01041781

Official Title:CALGB 80702: A Phase III Trial of 6 versus 12 Treatments of Adjuvant FOLFOX plus Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer
Date Window: 12/8/2010 - 12/8/2015
Contact for Details:Brenda Davis, RN 301-319-2367 or Ketly Bateau-Walker, RN 310-295-4374
Summary:To compare the effectiveness of 6 versus 12 courses of standard chemotherapy after surgery for stage III colon cancer; and to test how well celecoxib works at preventing colon cancer recurrence when added to chemotherapy.

 

ClinicalTrials.gov identifier
NCT01150045

 

 


Official Title:CALGB 80802: Phase III Randomized Study of Sorafenib plus Doxorubicin versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma (HCC)
Date Window: 6/12/2012 - 6/12/2017
Contact for Details:Brenda Davis, RN 301-319-2367 or Ketly Bateau-Walker, RN 310-295-4374
Summary:
To test how well chemotherapy works to treat advanced liver cancer when added to standard sorafenib treatment.

ClinicalTrials.gov identifier
NCT01015833


Official Title:ECOG 2906: Phase III Trial of Clofarabine as Induction and Post-Remission Therapy vs. Standard Daunorubicin & Cytarabine Induction and Intermediate Dose Cytarabine Post-Remission Therapy, Followed by Decitabine Maintenance vs. Observation in Newly-Diagnos
Date Window: 11/26/2012 - 11/26/2017
Contact for Details:Brenda Davis, RN 301-319-2367 or Ketly Bateau-Walker, RN 310-295-4374
Summary:
To compare the effectiveness of clofarabine to standard induction chemotherapy, and to test the effectiveness of decitabine as maintenance therapy, in patients over age 60 with acute myelogenous leukemia.

ClinicalTrials.gov identifier
NCT01041703


1 - 10 Next

Contact

Location
Building 17B
3rd Floor, Suite E

Phone
Main (301) 295-8239/8219

Hours of Operation
Monday thru Friday
0700 - 1630